- Medical researchers at UCI’s Beckman Laser Scanning Institute have developed optical, metabolic signatures for malignant breast cancer tumors.
- Traditional mammography often misses tumors in dense tissue.
- Young women with tumors are often mis-diagnosed.
Medical researchers at UC Irvine’s Beckman Laser Scanning Institute believe they have developed optical, metabolic signatures for malignant breast tumors. As my wife just finished a 5 year treatment for a pre-cancerous tissue this was all too familiar a discussion.
The researchers believe that the potential is there to identify breast tumors in dense tissue that are often not identified with traditional mammography. In certain cases contrast agents are needed and even then can be problematic in diagnosing tumors in young women where if present are particularly aggressive.
The technique can also be used during treatment to measure the effectiveness of the procedures. A larger research test suite is being planned.
